Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/7/26 17:13 | 4/6/26 | HALO | Health | BioPrd | Biological Products, (No Diag | Torley Helen | CA | DO | P,CEO | 10 | M.dm | 12,367 | 28.88 | 0 | 428 | 126 | 768 | D | ||||||||||||||
4/7/26 17:13 | 4/6/26 | HALO | Health | BioPrd | Biological Products, (No Diag | Torley Helen | CA | DO | P,CEO | 10 | S.dm | -12,367 | 28.88 | 0 | -428 | 768 | D | |||||||||||||||
3/10/26 19:18 | 3/9/26 | HALO | Health | BioPrd | Biological Products, (No Diag | Caudill Cortney | CA | O | SVP,COO | 3 | M.dm | 2,677 | 50.45 | 0 | 53 | 14 | D | |||||||||||||||
3/10/26 19:18 | 3/9/26 | HALO | Health | BioPrd | Biological Products, (No Diag | Caudill Cortney | CA | O | SVP,COO | 3 | S.dm | -2,677 | 50.45 | 0 | -53 | 14 | D | |||||||||||||||
2/24/26 18:16 | 2/20/26 | HALO | Health | BioPrd | Biological Products, (No Diag | Snyder Mark Howard | CA | O | SVP,GC | 2 | M.dm | 0 | 0.00 | 0 | 29 | 158 | 48 | D | ||||||||||||||
2/24/26 18:14 | 2/20/26 | HALO | Health | BioPrd | Biological Products, (No Diag | Labrosse Nicole | CA | O | SVP,CFO | 2 | M.dm | 0 | 0.00 | 0 | 36 | 999% | 38 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |